The Rise in Autism and the Role of Age at Diagnosis

Background: Autism prevalence in California, based on individuals eligible for state-funded services, rose throughout the 1990s. The extent to which this trend is explained by changes in age at diagnosis or inclusion of milder cases has not been previously evaluated. Methods: Autism cases were identified from 1990 through 2006 in databases of the California Department of Developmental Services, which coordinates services for individuals with specific developmental disorders. The main outcomes were population incident cases younger than age 10 years for each quarter, cumulative incidence by age and birth year, age-specific incidence rates stratified by birth year, and proportions of diagnoses by age across birth years. Results: Autism incidence in children rose throughout the period. Cumulative incidence to 5 years of age per 10,000 births rose consistently from 6.2 for 1990 births to 42.5 for 2001 births. Age-specific incidence rates increased most steeply for 2- and 3-year olds. The proportion diagnosed by age 5 years increased only slightly, from 54% for 1990 births to 61% for 1996 births. Changing age at diagnosis can explain a 12% increase, and inclusion of milder cases, a 56% increase. Conclusions: Autism incidence in California shows no sign yet of plateauing. Younger ages at diagnosis, differential migration, changes in diagnostic criteria, and inclusion of milder cases do not fully explain the observed increases. Other artifacts have yet to be quantified, and as a result, the extent to which the continued rise represents a true increase in the occurrence of autism remains unclear.

[1]  Susan Madden,et al.  Western psychological services , 1996 .

[2]  J P T Higgins,et al.  Systematic review of prevalence studies of autism spectrum disorders , 2005, Archives of Disease in Childhood.

[3]  E. Fombonne,et al.  Pervasive developmental disorders in preschool children. , 2001, JAMA.

[4]  I. Moilanen,et al.  Autism in Northern Finland , 2000, European Child & Adolescent Psychiatry.

[5]  J. Baio,et al.  Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, Number SS-10. , 2009 .

[6]  Eric Fombonne,et al.  Pervasive developmental disorders in preschool children: confirmation of high prevalence. , 2005, The American journal of psychiatry.

[7]  F. Volkmar At the Threshold: The Developing Adolescent , 1994 .

[8]  P. Decouflé,et al.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. , 2001, Pediatrics.

[9]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[10]  D. Geier,et al.  An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[11]  A. Mack,et al.  Continuing Increases in Autism Reported to California’s Developmental Services System: Mercury in Retrograde , 2009 .

[12]  Kathryn Hoberg Arehart,et al.  State of the States: The Status of Universal Newborn Hearing Screening, Assessment, and Intervention Systems in 16 States. , 1998, American journal of audiology.

[13]  Eric Fombonne,et al.  Epidemiology of autistic disorder and other pervasive developmental disorders. , 2005, The Journal of clinical psychiatry.

[14]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[15]  Irva Hertz-Picciotto,et al.  The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism , 2006, Environmental health perspectives.

[16]  S. Selvin,et al.  The Changing Prevalence of Autism in California , 2002, Journal of autism and developmental disorders.

[17]  G. Rosen MENTAL HEALTH IN THE UNITED STATES , 1962 .

[18]  W. Spitzer,et al.  Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), The Changing Prevalence of Autism in California , 2003, Journal of autism and developmental disorders.

[19]  Christine Yoshinaga-Itano,et al.  State of the States , 1998 .

[20]  H. Jick,et al.  Incidence of autism over time. , 2006, Epidemiology.

[21]  D. Geier,et al.  Early Downward Trends in Neurodevelopmental Disorders Following Removal of Thimerosal-Containing Vaccines , 2006 .

[22]  M. Blaxill Study Fails To Establish Diagnostic Substitution as a Factor in Increased Rate of Autism , 2004, Pharmacotherapy.

[23]  J. Bregman,et al.  Field trial for autistic disorder in DSM-IV. , 1994, The American journal of psychiatry.

[24]  G. Baird,et al.  A screening instrument for autism at 18 months of age: a 6-year follow-up study. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  H. Jick,et al.  Epidemiology and Possible Causes of Autism , 2003, Pharmacotherapy.

[26]  J. Kline,et al.  The autism epidemic: fact or artifact? , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.